208 related articles for article (PubMed ID: 11647286)
1. Proposal to test drugs in children meets resistance.
Pear R
N Y Times Web; 1997 Nov; ():1, 28. PubMed ID: 11647286
[No Abstract] [Full Text] [Related]
2. F.D.A. will require companies to test drugs on children.
Pear R
N Y Times Web; 1998 Nov; ():A1, A10. PubMed ID: 11647619
[No Abstract] [Full Text] [Related]
3. Twice wrong on AIDS.
Gieringer D
N Y Times Web; 1987 Jan; ():A21. PubMed ID: 11646161
[No Abstract] [Full Text] [Related]
4. Experimental drugs: more of them, but they're no longer free.
Caplan J
Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
[No Abstract] [Full Text] [Related]
5. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
Annas GJ
Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162
[No Abstract] [Full Text] [Related]
6. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
7. AIDS treatment drugs: clinical trials and compassionate use.
Levine RJ
AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
[No Abstract] [Full Text] [Related]
8. Trial of experimental AIDS drug to be continued, with revisions.
Kolata G
N Y Times Web; 1990 Mar; ():A1, A15. PubMed ID: 11646750
[No Abstract] [Full Text] [Related]
9. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
10. Testing drugs in pediatric populations: the FDA mandate.
Tauer CA
Account Res; 1999; 7(1):37-58. PubMed ID: 11657562
[No Abstract] [Full Text] [Related]
11. In business to treat cancer.
Henig RM
N Y Times Mag; 1986 Nov; ():68, 70, 78, 80+. PubMed ID: 11647805
[No Abstract] [Full Text] [Related]
12. Making experimental drugs available for AIDS treatment.
Krim M
AIDS Public Policy J; 1987; 2(2):1-5. PubMed ID: 11650026
[No Abstract] [Full Text] [Related]
13. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
14. Problems of drug testing in children in the United States.
Yaffe SJ
Pediatr Pharmacol (New York); 1983; 3(3-4):339-48. PubMed ID: 11659147
[No Abstract] [Full Text] [Related]
15. The regulation of clinical investigators.
Endries RN
Food Drug Cosmet Law J; 1980 Jul; 35(7):415-23. PubMed ID: 11661860
[No Abstract] [Full Text] [Related]
16. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
Dunbar MM
Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
[No Abstract] [Full Text] [Related]
17. Despite "clinical hold," subjects have right to keep getting experimental drug: Dahl v. HEM Pharmaceuticals Corporation (Part III).
Maloney DM
Hum Res Rep; 1996 Feb; 11(2):4-5. PubMed ID: 11654437
[No Abstract] [Full Text] [Related]
18. Data audit by a regulatory agency: its effect and implication for others.
Shapiro MF
Account Res; 1992; 2(3):219-29. PubMed ID: 11653981
[No Abstract] [Full Text] [Related]
19. If a subject incurs obligations and carries them out, then consent is a contract: Dahl v. HEM Pharmaceuticals (Part II).
Maloney DM
Hum Res Rep; 1996 Jan; 11(1):4-5. PubMed ID: 11653221
[No Abstract] [Full Text] [Related]
20. Risky alliance on medicine's cutting edge: firm faces business, ethics issues in NIH joint venture.
Lehrman S
Washington Post; 1991 Aug; ():Business 1, 14. PubMed ID: 11646923
[No Abstract] [Full Text] [Related]
[Next] [New Search]